Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India

被引:27
作者
Singh, Surjit [1 ]
Chandrakasan, Shanmuganathan [1 ]
Ahluwalia, Jasmina [2 ]
Suri, Deepti [1 ]
Rawat, Amit [1 ]
Ahmed, Nishath [1 ]
Das, Reena [2 ]
Sachdeva, M. U. S. [2 ]
Varma, Neelam [2 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Pediat, Adv Pediat Ctr, Pediat Allergy Immunol Unit, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Hematol, Chandigarh 160012, India
关键词
Macrophage activation syndrome; Reactive hemophagocytosis; Systemic onset juvenile idiopathic arthritis; India; INTRAVENOUS IMMUNOGLOBULIN THERAPY; KILLER-CELL DYSFUNCTION; RHEUMATOID-ARTHRITIS; HEMOPHAGOCYTIC SYNDROME; INFECTION; CHILDHOOD; COMPLICATION; INITIATION; DISORDERS;
D O I
10.1007/s00296-010-1711-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study is to describe the clinical and laboratory features of macrophage activation syndrome (MAS) in systemic onset juvenile idiopathic arthritis (SOJIA) at a tertiary care center in northwest India. Review of medical records of all children with SOJIA admitted during the period January 1995-December 2008 in Pediatric Allergy and Immunology Unit, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, was done. Six patients (5 boys and 1 girl) with SOJIA and MAS were identified. Mean age at time of disease onset was 6.5 years. MAS was the presenting manifestation of SOJIA in 4 patients. Clinical manifestations included fever (6/6), clinical shock (6/6), encephalopathy (5/6), generalized lymphadenopathy (4/6), hepatosplenomegaly (3/6), jaundice and abdominal tenderness (3/6), cardiac involvement (3/6), and meningeal irritation (2/6). Laboratory findings at onset of MAS included decreasing total leukocyte and platelet counts, coagulopathy, elevated transaminases, hyponatremia, and lipid abnormalities. Hemophagocytosis was demonstrable in the bone marrow in 4 patients and in the lymph node in 1. For treatment, we used intravenous methylprednisolone (4/6), oral prednisolone (2/6), and intravenous immunoglobulin (2/6). Outcome was favorable in all patients except one who died of rapidly progressive disease. This paper describes the experience of JIA-related macrophage activation syndrome in a tertiary Indian center. We have shown that MAS can be the early presenting manifestation of evolving SOJIA. Early diagnosis and aggressive management can have a significant impact on the mortality associated with this syndrome. We stress on the role of glucocorticoids in the management of this condition and believe that glucocorticoids have a far more important role in the management of this condition than what has been previously reported.
引用
收藏
页码:881 / 886
页数:6
相关论文
共 25 条
[1]   Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood [J].
Avcin, Tadej ;
Tse, Shirley M. L. ;
Schneider, Rayfel ;
Ngan, Bo ;
Silverman, Earl D. .
JOURNAL OF PEDIATRICS, 2006, 148 (05) :683-686
[2]  
Behrens EM, 2007, J RHEUMATOL, V34, P1133
[3]   The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis [J].
Bleesing, Jack ;
Prada, Anne ;
Siegel, David M. ;
Villanueva, Joyce ;
Olson, Judyann ;
Ilowite, Norman T. ;
Brunner, Hermine I. ;
Griffin, Thomas ;
Graham, Thomas B. ;
Sherry, David D. ;
Passo, Murray H. ;
Ramanan, Athimalaipet V. ;
Filipovich, Alexandra ;
Grom, Alexei A. .
ARTHRITIS AND RHEUMATISM, 2007, 56 (03) :965-971
[4]  
Chen Hsin-Hsu, 2007, Journal of Microbiology Immunology and Infection, V40, P265
[5]   Hemophagocytic syndrome as an initial presentation of miliary tuberculosis without pulmonary findings [J].
Dilber, E ;
Erduran, E ;
Kalyoncu, M ;
Aynaci, FM ;
Ökten, A ;
Ahmetoglu, A .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2002, 34 (09) :689-692
[6]  
Emmenegger U, 2002, SWISS MED WKLY, V132, P230
[7]   HEMOPHAGOCYTOSIS ACCOMPANYING TYPHOID-FEVER [J].
FAME, TM ;
ENGELHARD, D ;
RILEY, HD .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1986, 5 (03) :367-369
[8]   Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome [J].
Grom, AA ;
Villanueva, J ;
Lee, S ;
Goldmuntz, EA ;
Passo, MH ;
Filipovich, A .
JOURNAL OF PEDIATRICS, 2003, 142 (03) :292-296
[9]   ACUTE HEMORRHAGIC, HEPATIC, AND NEUROLOGIC MANIFESTATIONS IN JUVENILE RHEUMATOID-ARTHRITIS - POSSIBLE RELATIONSHIP TO DRUGS OR INFECTION [J].
HADCHOUEL, M ;
PRIEUR, AM ;
GRISCELLI, C .
JOURNAL OF PEDIATRICS, 1985, 106 (04) :561-566
[10]  
Ogawa Eiichi, 2008, Journal of Infection and Chemotherapy, V14, P377, DOI 10.1007/s10156-008-0636-x